Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vivien Davis Tsu

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|January 16, 2004
New and underused technologies to reduce maternal mortalityVivien Davis Tsu
American Journal of Public Health|December 30, 2006
Reconsidering the feasibility of papanicolaou and alternative screening tests for low-resource countriesVivien Davis Tsu
Nature|July 22, 2011
Indian vaccine study clarifiedVivien Davis Tsu
Lancet (London, England)|February 3, 2020
Cervical cancer elimination: are targets useful?Vivien Davis Tsu
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 11, 2017
Cervical cancer prevention for all women: Why now?Vivien Davis Tsu
American Journal of Law & Medicine|August 25, 2009
Overcoming barriers and ensuring access to HPV vaccines in low-income countriesVivien Davis Tsu
BJOG : an International Journal of Obstetrics and Gynaecology|August 17, 2005
Appropriate technology to prevent maternal mortality: current research requirementsVivien Davis Tsu
Journal of the Royal Society of Medicine|September 15, 2012
Should the ideal be the enemy of the good?Vivien Davis Tsu
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 11, 2017
The investment case for cervical cancer eliminationVivien Davis Tsu, Ophira Ginsburg
American Journal of Public Health|March 7, 2012
Human papillomavirus vaccine inaccuraciesVivien Davis Tsu, D Scott LaMontagne
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|January 16, 2004
New and underused technologies to reduce maternal mortalityVivien Davis Tsu
American Journal of Public Health|December 30, 2006
Reconsidering the feasibility of papanicolaou and alternative screening tests for low-resource countriesVivien Davis Tsu
Nature|July 22, 2011
Indian vaccine study clarifiedVivien Davis Tsu
Lancet (London, England)|February 3, 2020
Cervical cancer elimination: are targets useful?Vivien Davis Tsu
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 11, 2017
Cervical cancer prevention for all women: Why now?Vivien Davis Tsu
American Journal of Law & Medicine|August 25, 2009
Overcoming barriers and ensuring access to HPV vaccines in low-income countriesVivien Davis Tsu
BJOG : an International Journal of Obstetrics and Gynaecology|August 17, 2005
Appropriate technology to prevent maternal mortality: current research requirementsVivien Davis Tsu
Journal of the Royal Society of Medicine|September 15, 2012
Should the ideal be the enemy of the good?Vivien Davis Tsu
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 11, 2017
The investment case for cervical cancer eliminationVivien Davis Tsu, Ophira Ginsburg
American Journal of Public Health|March 7, 2012
Human papillomavirus vaccine inaccuraciesVivien Davis Tsu, D Scott LaMontagne
Pageof 2